Michel Janicot

2.3k total citations
45 papers, 1.6k citations indexed

About

Michel Janicot is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michel Janicot has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Michel Janicot's work include RNA Interference and Gene Delivery (7 papers), TGF-β signaling in diseases (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Michel Janicot is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), TGF-β signaling in diseases (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Michel Janicot collaborates with scholars based in United States, Netherlands and Belgium. Michel Janicot's co-authors include Annette Bakker, M. Daniel Lane, John C. McLenithan, Nico Janssens, Bernard Desbuquois, Jorge Vialard, Wim Floren, Andrew G. Swick, Luc Andries and Marcus E. Brewster and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Michel Janicot

44 papers receiving 1.6k citations

Peers

Countries citing papers authored by Michel Janicot

Since Specialization

Citations

This map shows the geographic impact of Michel Janicot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Janicot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Janicot more than expected).

Fields of papers citing papers by Michel Janicot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Janicot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Janicot. The network helps show where Michel Janicot may publish in the future.

Co-authorship network of co-authors of Michel Janicot

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Janicot. A scholar is included among the top collaborators of Michel Janicot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Janicot. Michel Janicot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis 2023 ·SHILAP Revista de lepidopterología ·Marion T.J. van den Bosch, (unknown), Sanaz Yahyanejad, (unknown), (unknown), Rogier M. Vos, Chantal L. Duurland, Rianne Biemans, Ludwig J. Dubois, Laurens A.H. van Pinxteren, Roel Q.J. Schaapveld, Michel Janicot	1
2	Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology 2021 ·Oncotarget ·(unknown), Sanaz Yahyanejad, (unknown), (unknown), Rogier M. Vos, (unknown), Marion T.J. van den Bosch, Mir Farshid Alemdehy, (unknown), Roel Q.J. Schaapveld, Michel Janicot	30
3	Transcriptome-wide analysis reveals insight into tumor suppressor functions of 1B3, a novel synthetic miR-193a-3p mimic 2021 ·Molecular Therapy — Nucleic Acids ·Marion T.J. van den Bosch, Sanaz Yahyanejad, Mir Farshid Alemdehy, (unknown), (unknown), (unknown), Rogier M. Vos, (unknown), Laurens A.H. van Pinxteren, Roel Q.J. Schaapveld, Michel Janicot	18
4	Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas 2019 ·Clinical Cancer Research ·(unknown), Manuela Silginer, Michael Weller, Hannah Schneider, Kathy Hasenbach, Michel Janicot, Patrick Roth	39
5	Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma 2017 ·Molecular Cancer Therapeutics ·Katharina Seystahl, (unknown), Isabel Burghardt, Hannah Schneider, Kathy Hasenbach, Michel Janicot, Patrick Roth, Michael Weller	45
6	An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages 2017 ·Annals of Oncology ·Isabel Huber‐Ruano, C. Raventós, Isabel Cuartas, (unknown), (unknown), Josep-Lluís Parra, Katja Wosikowski, Michel Janicot, Joan Seoane	24
7	Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-β) Isoform mRNAs for the Treatment of Solid Tumors 2015 ·Methods in molecular biology ·Frank Jaschinski, Hanna Korhonen, Michel Janicot	11
8	R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies 2007 ·British Journal of Cancer ·Janine Arts, Patrick Angibaud, (unknown), Wim Floren, (unknown), P King, Jacky Van Dun, Lut Janssen, (unknown), Robert W. Tuman, Dana L. Johnson, Luc Andries, Manfred Jung, Michel Janicot, Kristof Van Emelen	77
9	The Wnt-dependent signaling pathways as target in oncology drug discovery 2006 ·Investigational New Drugs ·Nico Janssens, Michel Janicot, (unknown)	55
10	Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes) 2006 ·Journal of drug targeting ·(unknown), Annette Bakker, (unknown), (unknown), Monique J. Bruining, C. Elissen‐Román, Michel Janicot, Marcus E. Brewster, Henk M. Janssen, Bas F. M. de Waal, Peter Fransen, Xianwen Lou, E. W. Meijer	68
11	Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: Toxicity, in vitro transfection and in vivo delivery 2006 ·Journal of Controlled Release ·(unknown), Annette Bakker, (unknown), (unknown), Monique J. Bruining, C. Elissen‐Román, Michel Janicot, Henk M. Janssen, Bas F. M. de Waal, Peter Fransen, Xianwen Lou, E. W. Meijer, Albertina Ariën, Marcus E. Brewster	7
12	Design and Analysis of Drug Combination Experiments 2005 ·Biometrical Journal ·Roel Straetemans, Timothy E. O’Brien, Luc Wouters, Jacky Van Dun, Michel Janicot, Luc Bijnens, Tomasz Burzykowski, Marc Aerts	61
13	Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles 2004 ·Cancer Biology & Therapy ·Suzie H. Pun, (unknown), Nathalie C. Bellocq, Jianjun Cheng, Brendan H. Grubbs, Gregory S. Jensen, Mark E. Davis, Marcus E. Brewster, Michel Janicot, (unknown), Wim Floren, Annette Bakker	156
14	Alteration of Frizzled Expression in Renal Cell Carcinoma 2004 ·Tumor Biology ·Nico Janssens, Luc Andries, Michel Janicot, (unknown), Annette Bakker	40
15	Housekeeping genes as internal standards in cancer research 2004 ·Molecular Diagnosis ·Nico Janssens, Michel Janicot, (unknown), Annette Bakker	63
16	Cellular Localization and Antiproliferative Effect of Peptides Discovered from a Functional Screen of a Retrovirally Delivered Random Peptide Library 2003 ·Chemistry & Biology ·Yasumichi Hitoshi, Tarikere Gururaja, Denise Pearsall, (unknown), Poonam Sharma, Betty Huang, Susan M. Catalano, John McLaughlin, Erlina S. Pali, Beau R. Peelle, Jorge Vialard, Michel Janicot, Walter Wouters, Walter Luyten, Mark K. Bennett, Dave Anderson, Donald G. Payan, James B. Lorens, (unknown), Susan D. Demo	13
17	Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Stefanie De Schepper, (unknown), Tinne Verhulst, (unknown), Luc Andries, Walter Wouters, Michel Janicot, Janine Arts, (unknown)	71
18	Cellular Interacting Proteins of Functional Screen-Derived Antiproliferative and Cytotoxic Peptides Discovered Using Shotgun Peptide Sequencing 2003 ·Chemistry & Biology ·Tarikere Gururaja, Weiqun Li, Susan M. Catalano, Jakob Bogenberger, Jing Zheng, Bernd O. Keller, Jorge Vialard, Michel Janicot, Liang Li, Yasumichi Hitoshi, Donald G. Payan, Dave Anderson	4
19	Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Patrick Angibaud, (unknown), David W. End, Eddy Freyne, Michel Janicot, (unknown), (unknown), Geert Mannens, (unknown), Laurence Mévellec, Christophe Meyer, Philippe Müller, (unknown), (unknown), Bruno Roux, G. Smets, Jacky Van Dun, P. Van Remoortere, Marc Venet, Walter Wouters	19
20	Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity 2002 ·British Journal of Cancer ·(unknown), R. Van Ginckel, (unknown), (unknown), Bieneke Janssen, Wim Floren, (unknown), Jacky Van Dun, Gérard Sanz, Marc Venet, Lieve Dillen, Carl Van Hove, G. Willemsens, Michel Janicot, Walter Wouters	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact